ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 128 filers reported holding ENANTA PHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is 4.27 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $2,692,000 | +585.0% | 58,920 | +960.1% | 0.00% | – |
| Q1 2022 | $393,000 | +7.4% | 5,558 | +14.2% | 0.00% | – |
| Q4 2021 | $366,000 | +4.6% | 4,868 | -20.9% | 0.00% | – |
| Q3 2021 | $350,000 | +10.1% | 6,155 | -6.3% | 0.00% | – |
| Q2 2021 | $318,000 | +32.0% | 6,570 | +33.8% | 0.00% | – |
| Q1 2021 | $241,000 | -3.2% | 4,909 | -4.2% | 0.00% | – |
| Q4 2020 | $249,000 | +170.7% | 5,126 | +164.0% | 0.00% | – |
| Q3 2020 | $92,000 | -21.4% | 1,942 | -15.6% | 0.00% | – |
| Q2 2020 | $117,000 | +290.0% | 2,301 | +288.0% | 0.00% | – |
| Q1 2020 | $30,000 | -81.6% | 593 | -77.6% | 0.00% | – |
| Q4 2019 | $163,000 | +30.4% | 2,642 | +26.2% | 0.00% | – |
| Q3 2019 | $125,000 | -35.6% | 2,094 | -9.0% | 0.00% | – |
| Q2 2019 | $194,000 | +162.2% | 2,300 | +198.3% | 0.00% | – |
| Q1 2019 | $74,000 | +21.3% | 771 | -11.4% | 0.00% | – |
| Q4 2018 | $61,000 | +8.9% | 870 | +33.0% | 0.00% | – |
| Q3 2018 | $56,000 | -97.6% | 654 | -96.7% | 0.00% | -100.0% |
| Q2 2018 | $2,328,000 | +6.5% | 20,082 | -25.6% | 0.00% | 0.0% |
| Q1 2018 | $2,185,000 | -5.9% | 27,007 | -31.7% | 0.00% | 0.0% |
| Q4 2017 | $2,322,000 | +40.7% | 39,562 | +12.2% | 0.00% | 0.0% |
| Q3 2017 | $1,650,000 | +1583.7% | 35,256 | +994.6% | 0.00% | – |
| Q1 2017 | $98,000 | -15.5% | 3,221 | -12.6% | 0.00% | – |
| Q4 2016 | $116,000 | +48.7% | 3,684 | +24.8% | 0.00% | – |
| Q3 2016 | $78,000 | +212.0% | 2,952 | +243.7% | 0.00% | – |
| Q1 2016 | $25,000 | -69.9% | 859 | -62.6% | 0.00% | – |
| Q3 2015 | $83,000 | +2666.7% | 2,296 | +2539.1% | 0.00% | – |
| Q1 2015 | $3,000 | -25.0% | 87 | -3.3% | 0.00% | – |
| Q2 2014 | $4,000 | – | 90 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 511,186 | $43,686,000 | 11.23% |
| GREAT POINT PARTNERS LLC | 210,400 | $17,981,000 | 2.80% |
| ARMISTICE CAPITAL, LLC | 456,000 | $38,970,000 | 2.34% |
| Matarin Capital Management, LLC | 210,208 | $17,964,376,000 | 1.16% |
| Sapphire Star Partners LP | 8,168 | $698,000 | 0.70% |
| Granahan Investment Management | 103,320 | $8,830,000 | 0.48% |
| FARALLON CAPITAL MANAGEMENT LLC | 867,500 | $74,137,000 | 0.44% |
| 361 CAPITAL LLC | 19,040 | $1,627,000 | 0.35% |
| ALGERT GLOBAL LLC | 17,922 | $1,532,000 | 0.33% |
| AlphaMark Advisors, LLC | 9,310 | $796,000 | 0.32% |